23 April 2024 - Paper outlines policy reforms and market actions to support innovation and access while managing uncertainty, affordability, ...
9 April 2024 - Input period now open until 13 May 2024. ...
11 December 2023 - Of 10 high expenditure drugs that had substantial 2022 net price increases, eight were not supported by ...
2 October 2023 - Report tailored to reflect legislative specifications in the Inflation Reduction Act and subsequent CMS guidance regarding ...
21 June 2023 - ICER’s third annual “Barriers to Fair Access” report will be published in November 2023. ...
19 April 2023 - White bagging, brown bagging, and site of service policies developed by payers can reduce significant markup costs ...
12 April 2023 - ICER will evaluate whether multiple formularies offered by the five largest US commercial payers, state health exchange ...
11 April 2023 - Annual unsupported price increase report to be published on December 12. ...
16 March 2023 - State policy makers and purchasers in California are uniquely positioned to further integrate comparative effectiveness research ...
10 March 2023 - This article provides systematic evidence on the share of the value of health generated by drugs and ...
10 March 2023 - Increases in drug prices and drug spending are of concern to health systems worldwide. This has naturally ...
17 January 2023 - During ICER’s assessment, five payers revised policies for 11 medicines in ways that bring coverage into ...
20 October 2022 - Unsupported Price Increase” final report based on drugs identified through SB-17, the California drug price transparency law. ...
11 October 2022 - State law makers, like their federal counterparts, are focused on addressing the high and growing cost of ...
11 October 2022 - Excitement is building about a new generation of drugs that tout the ability to help adults ...